Last reviewed · How we verify
NCT05694117
A Study of the Intervention Effect of a Hybrid Exercise Program on Elderly With Sarcopenia
NA trial testing self-determine sequence exercise program in Sarcopenia in 392 participants. Completed in 10 January 2020.
31 December 2019
Quick facts
| Lead sponsor | Northeast Normal University |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | double |
| Primary purpose | basic science |
| Enrollment | 392 |
| Start date | 20 March 2019 |
| Primary completion | 31 December 2019 |
| Estimated completion | 10 January 2020 |
| Sites | 1 location across China |
Drugs / interventions tested
- self-determine sequence exercise program
- resistance training
- Taichi exercise and resistance training
- Randomly selected exercise program
Conditions studied
- Sarcopenia — all drugs for Sarcopenia →
Sponsor
Northeast Normal University
Who can join
Adults 60 to 75, any sex, with Sarcopenia. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Sarcopenia is a geriatric condition characterized by a progressive decrease in skeletal muscle content and loss of muscle function. Resistance exercise, Taichi exercise and the hybrid exercise program consisting of the two aforementioned methods have been demonstrated could increase the skeletal muscle mass of the elderly with sarcopenia. However, note that the above contents may be performed in a different order in a treatment, equally important but less well understood is the sequence in which it should be performed. Surprisingly, the exercise sequence has not been comprehensively investigated. Therefore, investigators designed a self-ordered exercise program combining resistance exercise, tai chi and a hybrid exercise program to investigate whether the decline in skeletal muscle area could be better overcome and the reversal of sarcopenia in elderly with sarcopenia.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Quantifying the Enhancement of Sarcopenic Skeletal Muscle Preservation Through a Hybrid Exercise Program: Randomized Controlled Trial.
Guo H, Cao J, He S, Wei M, et al · · 2024 · cited 8× · PMID 39621937 · DOI 10.2196/58175
Verify or expand the search:
- PubMed search for NCT05694117
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Sarcopenia
Currently open trials in the same condition.
- NCT07500376 — Multimodal Nutritional and Sarcopenia Assessment for Risk Stratification in Lung Cancer Surgery · recruiting
- NCT07456956 — HIIT vs MCIT for Stroke-Related Sarcopenia in Ischemic Stroke · NA · recruiting
- NCT07398495 — Multimodal Training Effects in Middle-Aged and Older Adults With Diabetic Sarcopenia · NA · recruiting
- NCT07494916 — Effects of Functional Task Training on Muscle Health and Function in Older Adults With Sarcopenia · NA · active not recruiting
- NCT07426159 — AI-Guided Sarcopenia Risk Assessment and Detection · NA · active not recruiting
Other Northeast Normal University trials
Trials by the same sponsor.
- NCT07446530 — Research on the Impact of Gamification Movement on Children With Sensory Integration Disorders · NA · enrolling by invitation
- NCT07259694 — RCT on Traditional Exercise Interventions for Physical and Mental Health in Hearing-Impaired Individuals · NA · enrolling by invitation
- NCT07265024 — Traditional Exercise RCT in Visually Impaired Adults · NA · enrolling by invitation
- NCT06547996 — Effects of tES Combined With Retrieval Practice on Semantic Memory in Patients With Schizophrenia · NA · completed
- NCT06466057 — Metacognitive Therapy for Obsessive-Compulsive Disorder · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05694117 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Northeast Normal University
- Last refreshed: 9 February 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05694117.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing